CXCR3 and alkaline phosphatase measurement: Thus, our current data provide new insights into the future development of anti-inflammatory therapeutic regimens targeting the CXCL9-CXCR3 axis that promote accelerated healing and reduce inflammatory bone destruction in cases of AP (Fig. 7).